Forecast

The analysts' average price target is €4.10 (+37.58%). The median is €4.10 (+37.58%).

Buy	6
Hold	3
Sell	0

News Go to news feed

Sensus Healthcare: shareholders re-elect directors and ratify auditor

At Sensus Healthcare’s annual meeting, Eric Sachetta and Michael J. Sardano were re-elected as Class II directors for three-year terms. Shareholders also voted, in a non-binding advisory vote, to approve executive compensation for 2025 and ratified Carr, Riggs & Ingram as the independent auditor for fiscal year 2026. Sensus reported weak Q1 results with EPS of -$0.16 and revenue of $3.4 million, while the stock is trading near its 52-week low. » More on de.investing.com
Sensus Healthcare misses Q1 forecasts after sharp revenue decline

Sensus Healthcare reported Q1 2026 EPS of -$0.16 and revenue of $3.4 million, both below analyst expectations. Revenue fell 59% year over year, weighed down by missed sales to its largest customer and a shift to new business models. Adjusted revenue growth on a comparable basis was +26%. Management sees potential in new specific CPT codes and the Sensus Link software platform to improve reimbursement and drive future revenue growth. » More on de.investing.com
Acquisition leads to change of auditor at Sensus Healthcare

Sensus Healthcare dismissed Berkowitz Pollack Brant Advisors + CPAs (BPB) and appointed Carr, Riggs & Ingram (CRI) as its new independent auditor after CRI acquired certain assets of BPB’s capital markets business (effective Jan. 1, 2026). BPB’s audit report for the fiscal year ended Dec. 31, 2024, contained no disclaimers, modifications or disagreements with Sensus. The company also reported that a previously disclosed material IT-related control weakness had been remediated as of Dec. 31, 2024. In addition, Sensus reported revenue that exceeded expectations in the third quarter of 2025 and several board and management personnel changes, including the appointment of Larry Biscotti to the board of directors and the promotion of Michael Sardano to chief commercial officer. » More on de.investing.com

Financials

In the last quarter, SENSUS HEALTHCARE DL-,01 Aktie had revenue of €2.01M and net profit of -€7.67M

(EUR)	Jun 2026	YoY
Revenue	2.01M	67.67%
Gross profit	673.81K	72.64%
Net profit	-7.67M	771.32%
EBITDA	-2.71M	99.46%

Fundamentals

Metric	Value
Market capitalization	€49.98M
Number of shares	16.46M
52-week high/low	€4.74 - €2.29
Dividends	No
Beta	1.12
P/E ratio	-3.75
PEG ratio	0.04
P/B ratio	1.57
P/S ratio	3.31

Company profile

Sensus Healthcare, Inc. ist ein Medizintechnikunternehmen, das Geräte für die Strahlentherapie herstellt und an Gesundheitsdienstleister weltweit verkauft. Das Unternehmen verwendet in seinem Portfolio von Behandlungsgeräten die oberflächliche Strahlentherapie (SRT), eine Röntgentechnologie mit niedriger Energie. Das Unternehmen bietet das SRT-100 an, ein oberflächliches Röntgensystem mit niedriger Energie, das Patienten eine Alternative zur Operation bei der Behandlung von Nicht-Melanom-Hautkrebs, einschließlich Basalzell- und Plattenepithelkarzinomen, sowie anderen Hautkrankheiten, wie Keloiden, bietet. Das SRT-100 Vision bietet dem Anwender eine auf die SRT zugeschnittene Behandlungsplanungsanwendung, die das eingebettete Hochfrequenz-Ultraschall-Bildgebungsmodul, die volumetrische Tumoranalyse, die Planung von Strahlenrändern und Dosimetrieparameter integriert. Das Unternehmen bietet außerdem das SRT-100 Plus, das Sentinel-Serviceprogramm, das seinen Kunden Schutz für ihre Systeme bietet, und den Verleih von Lasern für die Praxis an. Darüber hinaus vertreibt das Unternehmen Einweg-Bleiabschirmungen und Einweg-Strahlenschutzartikel wie Schürzen und Augenschützer, Ultraschallsondenfolien und Einweg-Applikatorspitzen zur Behandlung von Läsionen unterschiedlicher Größe und verschiedener Körperregionen. Sensus Healthcare, Inc. wurde im Jahr 2010 gegründet und hat seinen Hauptsitz in Boca Raton, Florida.

Name	SENSUS HEALTHCARE DL-,01 Aktie
CEO	Joseph C. Sardano
Headquarters	Boca Raton, fl USA
Website	sensushealthcare.com
Sector	Consumer Discretionary
Industry	Household Durables
IPO	07/26/2016
Employees	60